A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

NCT05023915 PHASE2 ACTIVE_NOT_RECRUITING

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsule plus high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).

Details

Lead sponsor	Shandong University
Phase	PHASE2
Status	ACTIVE_NOT_RECRUITING
Enrolment	106
Start date	Sat Aug 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Jan 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Immune Thrombocytopenia

Interventions

• dexamethasone
• diammonium glycyrrhizinate enteric-coated capsule

Countries

China